Avantor reports Q1 adjusted EPS 22c, consensus 20c

Reports Q1 revenue $1.68B, consensus $1.68B. “The year is off to a good start as first quarter organic revenue growth was in line with our guidance and disciplined execution drove outperformance on margins and profitability. We are encouraged by the relative stability of our end markets, the impact of our commercial intensity on customer wins and contract renewals, and the sequential improvement in our bioprocessing orders,” said Michael Stubblefield, President and Chief Executive Officer.